Evidence map›Paper›PMID 34748918›Full record

ArticleThe Journal of nutritional biochemistry2022

Dietary supplementation of gingerols- and shogaols-enriched ginger root extract attenuate pain-associated behaviors while modulating gut microbiota and metabolites in rats with spinal nerve ligation.

Chwan-Li Shen, Rui Wang, Guangchen Ji, Moamen M Elmassry, Masoud Zabet-Moghaddam, Heather Vellers, Abdul N Hamood, Xiaoxia Gong, Parvin Mirzaei, Shengmin Sang and 1 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06817018 (Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06817018 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals

TypeinterventionalSponsorLeslie ShenRan2025 to 2028Enrolled80ConditionsNeuropathic Pain, Sciatic PainArmsPlacebo, Ginger
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. 6-gingerol and its derivatives inhibitFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Chwan-Li ShenDepartment of Pathology, Texas Technical University Health Sciences Center, Lubbock, Texas; Center of Excellence for Integrative Health, Texas Technical University Health Sciences Center, Lubbock, Texas; Center of Excellence for Translational Neuroscience and Therapeutics, Texas Technical University Health Sciences Center, Lubbock, Texas. Electronic address: leslie.shen@ttuhsc.edu.
Rui WangDepartment of Pathology, Texas Technical University Health Sciences Center, Lubbock, Texas.
Guangchen JiDepartment of Pharmacology and Neuroscience, Texas Technical University Health Sciences Center, Lubbock, Texas.
Moamen M ElmassryDepartment of Biological Sciences, Texas Technical University, Lubbock, Texas.
Masoud Zabet-MoghaddamCenter for Biotechnology and Genomics, Texas Technical University, Lubbock, Texas.
Heather VellersDepartment of Kinesiology and Sport Management, Texas Technical University, Lubbock, Texas.
Abdul N HamoodDepartment of Immunology and Molecular Microbiology, Texas Technical University Health Sciences Center, Lubbock, Texas; Department of Surgery, Texas Technical University Health Sciences Center, Lubbock, Teaxs.
Xiaoxia GongCenter for Biotechnology and Genomics, Texas Technical University, Lubbock, Texas.
Parvin MirzaeiCenter for Biotechnology and Genomics, Texas Technical University, Lubbock, Texas.
Shengmin SangLaboratory for Functional Foods and Human Health, Center for Excellence in Post Harvest Technologies, North Carolina A&T State University, North Carolina Research Campus, Kannapolis, North Carolina.
Volker NeugebauerCenter of Excellence for Integrative Health, Texas Technical University Health Sciences Center, Lubbock, Texas; Center of Excellence for Translational Neuroscience and Therapeutics, Texas Technical University Health Sciences Center, Lubbock, Texas; Department of Pharmacology and Neuroscience, Texas Technical University Health Sciences Center, Lubbock, Texas.
Texas Tech University · USTexas Tech University Health Sciences Center · USNorth Carolina Agricultural and Technical State University · US

Funding

PAIN, NOCICEPTION, AND THE AMYGDALAR01NS038261 · NINDS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Volker Neugebauer, Igor Ponomarev · 1999 to 2026
$8.7M
NINDS NIH HHS R01 NS038261
6 · The paper itself

Abstract

Neuroinflammation is a central factor in neuropathic pain (NP). Ginger is a promising bioactive compound in NP management due to its anti-inflammatory property. Emerging evidence suggests that gut microbiome and gut-derived metabolites play a key role in NP. We evaluated the effects of two ginger root extracts rich in gingerols (GEG) and shogaols (SEG) on pain sensitivity, anxiety-like behaviors, circulating cell-free mitochondrial DNA (ccf-mtDNA), gut microbiome composition, and fecal metabolites in rats with NP. Sixteen male rats were divided into four groups: sham, spinal nerve ligation (SNL), SNL+0.75%GEG in diet, and SNL+0.75%SEG in diet groups for 30 days. Compared to SNL group, both SNL+GEG and SNL+SEG groups showed a significant reduction in pain- and anxiety-like behaviors, and ccf-mtDNA level. Relative to the SNL group, both SNL+GEG and SNL+SEG groups increased the relative abundance of Lactococcus, Sellimonas, Blautia, Erysipelatoclostridiaceae, and Anaerovoracaceae, but decreased that of Prevotellaceae UCG-001, Rikenellaceae RC9 gut group, Mucispirillum and Desulfovibrio, Desulfovibrio, Anaerofilum, Eubacterium siraeum group, RF39, UCG-005, Lachnospiraceae NK4A136 group, Acetatifactor, Eubacterium ruminantium group, Clostridia UCG-014, and an uncultured Anaerovoracaceae. GEG and SEG had differential effects on gut-derived metabolites. Compared to SNL group, SNL+GEG group had higher level of 1'-acetoxychavicol acetate, (4E)-1,7-Bis(4-hydroxyphenyl)-4-hepten-3-one, NP-000629, 7,8-Dimethoxy-3-(2-methyl-3-buten-2-yl)-2H-chromen-2-one, 3-{[4-(2-Pyrimidinyl)piperazino]carbonyl}-2-pyrazinecarboxylic acid, 920863, and (1R,3R,7R,13S)-13-Methyl-6-methylene-4,14,16-trioxatetracyclo[11.2.1.0∼1,10∼.0∼3,7∼]hexadec-9-en-5-one, while SNL+SEG group had higher level for (±)-5-[(tert-Butylamino)-2'-hydroxypropoxy]-1_2_3_4-tetrahydro-1-naphthol and dehydroepiandrosteronesulfate. In conclusion, ginger is a promising functional food in the management of NP, and further investigations are necessary to assess the role of ginger on gut-brain axis in pain management.

Indexed as

Dietary SupplementsGastrointestinal MicrobiomePlant ExtractsZingiber officinaleAnimalsBacteriaCatecholsDNA, MitochondrialFatty AlcoholsFecesGastrointestinal TractLigationMaleNeuralgiaPain ManagementRatsCatecholsDNA, MitochondrialFatty Alcoholsginger extractgingerolPlant ExtractsshogaolanimalsanxietyBioactive compoundfecal metabolitesgut microbiomeneuropathic pain

Identifiers

PMID34748918
PMCPMC8794052
OpenAlexW3214509966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.